| P2093 | author name string | Kyu Tae Lee | |
| | Sung Kyu Maeng | |
| | Kyung Guen Song | |
| | Byeong Gyu Choi | |
| P2860 | cites work | Fluorescence excitation-emission matrix regional integration to quantify spectra for dissolved organic matter | Q30887342 |
| | A novel enzyme-linked immunosorbent assay for ethynylestradiol using a long-chain biotinylated EE2 derivative | Q30936992 |
| | The link between nitrification and biotransformation of 17alpha-ethinylestradiol | Q31118700 |
| | Nitrification activity and community structure of nitrite-oxidizing bacteria in the bioreactors operated with addition of pharmaceuticals | Q33819389 |
| | Effect of solids retention time on antibiotics removal performance and microbial communities in an A/O-MBR process | Q34111577 |
| | Multivariate statistically-based modelling of a membrane bioreactor for wastewater treatment using 2D fluorescence monitoring data | Q34263831 |
| | Scrutinizing pharmaceuticals and personal care products in wastewater treatment. | Q35949321 |
| | Fate, transport, and biodegradation of natural estrogens in the environment and engineered systems | Q36672977 |
| | Removal mechanisms for endocrine disrupting compounds (EDCs) in wastewater treatment - physical means, biodegradation, and chemical advanced oxidation: a review. | Q37321159 |
| | Combination of Advanced Oxidation Processes and biological treatments for wastewater decontamination--a review. | Q37801112 |
| | Processes for the elimination of estrogenic steroid hormones from water: a review | Q37991882 |
| | Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment--a review | Q38009960 |
| | Fate of estrogenic hormones in wastewater and sludge treatment: A review of properties and analytical detection techniques in sludge matrix | Q38039741 |
| | Removal of carbamazepine and sulfamethoxazole by MBR under anoxic and aerobic conditions | Q38420799 |
| | Development of a stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line | Q40953839 |
| | Analysis of pharmaceuticals in wastewater and removal using a membrane bioreactor | Q42075940 |
| | Occurrence and removal of pharmaceutically active compounds in sewage treatment plants with different technologies | Q43298024 |
| | The characteristics of enriched nitrifier culture in the degradation of selected pharmaceutically active compounds. | Q43307525 |
| | Influence of microbial activity on polar xenobiotic degradation in activated sludge systems | Q43319858 |
| | An assessment of endocrine disrupting activity changes during wastewater treatment through the use of bioassays and chemical measurements | Q43320040 |
| | Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. | Q43328271 |
| | Sorption of emerging trace organic compounds onto wastewater sludge solids. | Q43329325 |
| | Outcomes of a 2-year investigation on enhanced biological nutrients removal and trace organics elimination in membrane bioreactor (MBR). | Q43331825 |
| | Fate of natural estrogens in batch mixing experiments using municipal sewage and activated sludge. | Q43332449 |
| | Spectrometric characterization of effluent organic matter of a sequencing batch reactor operated at three sludge retention times. | Q43335410 |
| | Assessing the removal of pharmaceuticals and personal care products in a full-scale activated sludge plant. | Q43338518 |
| | Influence of nitrifying conditions on the biodegradation and sorption of emerging micropollutants. | Q43347942 |
| | Elimination of selected acidic pharmaceuticals from municipal wastewater by an activated sludge system and membrane bioreactors | Q43348714 |
| | Effects of effluent organic matter characteristics on the removal of bulk organic matter and selected pharmaceutically active compounds during managed aquifer recharge: Column study | Q43350018 |
| | Fate of estrogens during the biological treatment of synthetic wastewater in a nitrite-accumulating sequencing batch reactor | Q43364119 |
| | Influence of manganese and ammonium oxidation on the removal of 17 alpha-ethinylestradiol (EE2). | Q43365879 |
| | Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. | Q43366785 |
| | Biological removal of 17alpha-ethinylestradiol by a nitrifier enrichment culture in a membrane bioreactor | Q43368593 |
| | Simultaneous determination of endocrine disrupting phenolic compounds and steroids in water by solid-phase extraction-gas chromatography-mass spectrometry | Q44749915 |
| | Pharmaceutical residues in the river Rhine--results of a one-decade monitoring programme | Q46300197 |
| | 17alpha-Ethinylestradiol sorption to activated sludge biomass: thermodynamic properties and reaction mechanisms | Q46649599 |
| | Characterisation of aquatic humic and non-humic matter with size-exclusion chromatography – organic carbon detection – organic nitrogen detection (LC-OCD-OND) | Q47410372 |
| | Effects of bacterial activity on estrogen removal in nitrifying activated sludge. | Q50989609 |
| | Comparison of PPCPs removal on a parallel-operated MBR and AS system and evaluation of effluent post-treatment on vertical flow reed beds. | Q53403347 |
| | Analysis and removal of emerging contaminants in wastewater and drinking water | Q57237824 |
| | Fate of pharmaceuticals and cosmetic ingredients during the operation of a MBR treating sewage | Q58462111 |
| | Comparison of removal of pharmaceuticals in MBR and activated sludge systems | Q62608008 |
| | Enhanced biodegradation of iopromide and trimethoprim in nitrifying activated sludge | Q79443735 |
| | Suspended biofilm carrier and activated sludge removal of acidic pharmaceuticals | Q83157396 |
| | Fate of antibiotics in activated sludge followed by ultrafiltration (CAS-UF) and in a membrane bioreactor (MBR) | Q84565767 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bioreactor | Q864699 |
| | estrogen | Q277954 |
| P1104 | number of pages | 12 | |
| P304 | page(s) | 3151-3162 | |
| P577 | publication date | 2013-03-21 | |
| P1433 | published in | Water Research | Q15708879 |
| P1476 | title | Influences of solid retention time, nitrification and microbial activity on the attenuation of pharmaceuticals and estrogens in membrane bioreactors | |
| P478 | volume | 47 | |